← Back to Clinical Trials
Recruiting NCT07812896

NCT07812896 Smart Baby Monitor Effects on Infant Sleep and Parent Well-being

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07812896
Status Recruiting
Phase —
Sponsor Udisense DBA Nanit
Condition Infant Sleep Problem
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2026-07-15
Primary Completion 2027-04-15

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Smart Baby Monitor with Sleep Analytics and Behavioral GuidanceSmart Baby Monitor with Live Video Only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2026-07-15 with a primary completion date of 2027-04-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn whether a smart baby monitor with full sleep analytics and behavioral guidance improves infant sleep and parent well-being in first-time parents during the first six months after birth. The main questions it aims to answer are: 1. Does access to Nanit's full monitoring features improve infant nighttime sleep - including total sleep time, bedtime consistency, nighttime awakenings, and how often parents need to intervene at night? 2. Does it improve sleep quality and mental health outcomes for parents, including reduced postpartum depression and anxiety symptoms? Researchers will compare families using the Nanit camera with full Milestone Insights features (sleep analytics, behavioral guidance, and developmental tracking) to families using the Nanit camera with live video only, to see whether the full suite of features leads to better sleep and well-being outcomes.

Eligibility Criteria

Inclusion Criteria: * Primary caregiver is biological parent * Expecting first child (nulliparous) * Currently between 34 weeks of gestation and end of gestation * Primary caregiver aged 21 or older * Access to a smartphone or tablet compatible with the Nanit application * Able to complete study surveys in English * Any family structure (single parent, coupled, same-sex couples, etc.) Exclusion Criteria: * Infant born prior to 35 weeks gestational age (preterm birth) * Infant born with a severe medical condition requiring intensive neonatal care at time of study measures * Multiple gestation (twins, triplets, or higher-order multiples) * Prior children living in the household (not first-time parents) * Primary caregiver works shift work or irregular schedules * Primary caregiver diagnosed with a sleep disorder (OSA, RLS, PLMD, RBD, or other)

Contact & Investigator

Central Contact

Natalie Barnett, PhD

✉ natalie.barnett@nanit.com

📞 +1 (866) 696-2648

Frequently Asked Questions

Who can join the NCT07812896 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, studying Infant Sleep Problem. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07812896 currently recruiting?

Yes, NCT07812896 is actively recruiting participants. Contact the research team at natalie.barnett@nanit.com for enrollment information.

Where is the NCT07812896 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07812896 clinical trial?

NCT07812896 is sponsored by Udisense DBA Nanit. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology